Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Gerhard

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
JAMA Psychiatry|February 21, 2019
Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With SchizophreniaT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.
The Annals of Pharmacotherapy|April 6, 2006
Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugsIssam Zineh, Glenn D Pebanco, Christina L Aquilante, et al.
Sleep|March 2, 2024
Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysisGreta Bushnell, Anna Ivanenko, Daniel B Horton, et al.
Plos One|September 25, 2019
Comparing record linkage software programs and algorithms using real-world dataAlan F Karr, Matthew T Taylor, Suzanne L West, et al.
Psychiatric Services (Washington, D.C.)|April 3, 2018
Psychotropic Medication Use Among Adults With Schizophrenia and Schizoaffective Disorder in the United StatesT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.
Drug and Alcohol Dependence|December 16, 2025
Prescribing of controlled substances to adolescents and young adults enrolled in Medicaid, 2001-2019Greta Bushnell, Mark Olfson, Kristen Lloyd, et al.
BMJ (Clinical Research Ed.)|July 20, 2012
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort studyAlmut G Winterstein, Tobias Gerhard, Paul Kubilis, et al.
Pharmacoepidemiology and Drug Safety|March 8, 2018
Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort studyWei Liu, Patrick J Antonelli, Philipp Dahm, et al.
Clinical Cardiology|August 28, 2009
Systolic blood pressure and subjective well-being in patients with coronary artery diseaseYan Gong, Eileen M Handberg, Tobias Gerhard, et al.
Addiction (Abingdon, England)|October 10, 2023
Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individualsGreta A Bushnell, Moira A Rynn, Tobias Gerhard, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
JAMA Psychiatry|February 21, 2019
Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With SchizophreniaT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.
The Annals of Pharmacotherapy|April 6, 2006
Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugsIssam Zineh, Glenn D Pebanco, Christina L Aquilante, et al.
Sleep|March 2, 2024
Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysisGreta Bushnell, Anna Ivanenko, Daniel B Horton, et al.
Plos One|September 25, 2019
Comparing record linkage software programs and algorithms using real-world dataAlan F Karr, Matthew T Taylor, Suzanne L West, et al.
Psychiatric Services (Washington, D.C.)|April 3, 2018
Psychotropic Medication Use Among Adults With Schizophrenia and Schizoaffective Disorder in the United StatesT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.
Drug and Alcohol Dependence|December 16, 2025
Prescribing of controlled substances to adolescents and young adults enrolled in Medicaid, 2001-2019Greta Bushnell, Mark Olfson, Kristen Lloyd, et al.
BMJ (Clinical Research Ed.)|July 20, 2012
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort studyAlmut G Winterstein, Tobias Gerhard, Paul Kubilis, et al.
Pharmacoepidemiology and Drug Safety|March 8, 2018
Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort studyWei Liu, Patrick J Antonelli, Philipp Dahm, et al.
Clinical Cardiology|August 28, 2009
Systolic blood pressure and subjective well-being in patients with coronary artery diseaseYan Gong, Eileen M Handberg, Tobias Gerhard, et al.
Addiction (Abingdon, England)|October 10, 2023
Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individualsGreta A Bushnell, Moira A Rynn, Tobias Gerhard, et al.
Pageof 10